Phibro Animal Health | PAHC - 销售毛利

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.34B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	销售毛利	更改		日
Align Technology	USD 683.59M		44.39M	2025-12
ANI Pharmaceuticals	USD 124.18M		12.39M	2025-12
Assertio Holdings	USD 22.24M		970K	2024-06
Aurora Cannabis	CAD 46.62M		14.33M	2025-12
Bristol-Myers Squibb	USD 8.79B		110M	2025-09
Canopy Growth	CAD 21.47M		434K	2025-12
Corcept Therapeutics	USD 199.58M		3.46M	2025-12
Eli Lilly	USD 14.59B		1.48B	2025-09
Henry Schein	USD 1.06B		37M	2025-12
Idexx Laboratories	USD 658.11M		25.24M	2025-12
Knight Therapeutics	CAD 64.72M		8.91M	2025-12
Merck	USD 13.42B		431M	2025-09
Nektar Therapeutics	USD 21.81M		8.06M	2025-12
Pacira	USD 142.25M		11.34M	2025-12
Phibro Animal Health	USD 133.5M		12.6M	2025-12
Prestige Brands	USD 157.37M		5.79M	2025-12
Supernus Pharmaceuticals	USD 164.04M		15.23M	2025-12
Zoetis	USD 1.64B		73M	2025-12